NCT04631588 - Intradermal (ID) BOTOX in the Treatment of Facial Fine Lines | Biotech Hunter

Enrollment

172

Participants

Timeline

Start Date

November 16, 2020

Primary Completion Date

November 3, 2021

Study Completion Date

November 3, 2021

Conditions

Facial Fine Lines

Interventions

DRUG

Botox

Intradermal (ID) injection

DRUG

Placebo

Intradermal (ID) injection

Trial Locations (5)

Austin Institute for Clinical Research /ID# 225154, Pflugerville

Skin and Cancer Associates, LLP /ID# 225152, Miami

Laser & Skin Surgery Center of New York /ID# 225153, New York

Tennessee Clinical Research Center /ID# 225151, Nashville

Advanced Clinical Research /ID# 225155, Salt Lake City